Search details
1.
Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
J Virol
; 91(19)2017 10 01.
Article
in English
| MEDLINE | ID: mdl-28724768
2.
Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
J Virol
; 89(6): 3221-35, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25568203
3.
Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides.
Bioconjug Chem
; 26(8): 1713-23, 2015 Aug 19.
Article
in English
| MEDLINE | ID: mdl-26193334
4.
Novel synthetic toll-like receptor 4/MD2 ligands attenuate sterile inflammation.
J Pharmacol Exp Ther
; 350(2): 330-40, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24893985
5.
Discovery of substituted 4-aminoquinazolines as selective Toll-like receptor 4 ligands.
Bioorg Med Chem Lett
; 24(21): 4931-8, 2014 Nov 01.
Article
in English
| MEDLINE | ID: mdl-25288184
6.
Cutting edge: nitrogen bisphosphonate-induced inflammation is dependent upon mast cells and IL-1.
J Immunol
; 188(7): 2977-80, 2012 Apr 01.
Article
in English
| MEDLINE | ID: mdl-22387558
7.
Role of IL-1 receptor-associated kinase-M (IRAK-M) in priming of immune and inflammatory responses by nitrogen bisphosphonates.
Proc Natl Acad Sci U S A
; 108(27): 11163-8, 2011 Jul 05.
Article
in English
| MEDLINE | ID: mdl-21690387
8.
JNK1 controls mast cell degranulation and IL-1{beta} production in inflammatory arthritis.
Proc Natl Acad Sci U S A
; 107(51): 22122-7, 2010 Dec 21.
Article
in English
| MEDLINE | ID: mdl-21135226
9.
Mast cell-mediated inhibition of abdominal neutrophil inflammation by a PEGylated TLR7 ligand.
Mediators Inflamm
; 2012: 262394, 2012.
Article
in English
| MEDLINE | ID: mdl-22619481
10.
Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling.
J Exp Med
; 197(4): 537-42, 2003 Feb 17.
Article
in English
| MEDLINE | ID: mdl-12591910
11.
Intravesical Toll-like receptor 7 agonist R-837: optimization of its formulation in an orthotopic mouse model of bladder cancer.
Int J Urol
; 17(5): 483-90, 2010 May.
Article
in English
| MEDLINE | ID: mdl-20337728
12.
Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.
PLoS One
; 10(11): e0142487, 2015.
Article
in English
| MEDLINE | ID: mdl-26554380
13.
Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes.
PLoS One
; 10(6): e0129867, 2015.
Article
in English
| MEDLINE | ID: mdl-26076454
14.
A window-of-opportunity biomarker study of etodolac in resectable breast cancer.
Cancer Med
; 4(10): 1583-8, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26275572
15.
Innate immune protection against infectious diseases by pulmonary administration of a phospholipid-conjugated TLR7 ligand.
J Innate Immun
; 6(3): 315-24, 2014.
Article
in English
| MEDLINE | ID: mdl-24192551
16.
Inhibition of keratinocyte proliferation by phospholipid-conjugates of a TLR7 ligand in a Myc-induced hyperplastic actinic keratosis model in the absence of systemic side effects.
Eur J Dermatol
; 23(5): 618-28, 2013.
Article
in English
| MEDLINE | ID: mdl-24225049
17.
Transcriptome sequencing of tumor subpopulations reveals a spectrum of therapeutic options for squamous cell lung cancer.
PLoS One
; 8(3): e58714, 2013.
Article
in English
| MEDLINE | ID: mdl-23527012
18.
Identification of substituted pyrimido[5,4-b]indoles as selective Toll-like receptor 4 ligands.
J Med Chem
; 56(11): 4206-23, 2013 Jun 13.
Article
in English
| MEDLINE | ID: mdl-23656327
19.
Treatment of autoimmune inflammation by a TLR7 ligand regulating the innate immune system.
PLoS One
; 7(9): e45860, 2012.
Article
in English
| MEDLINE | ID: mdl-23029281
20.
Detection of low prevalence somatic mutations in solid tumors with ultra-deep targeted sequencing.
Genome Biol
; 12(12): R124, 2011 Dec 20.
Article
in English
| MEDLINE | ID: mdl-22185227